Regarding longitudinal FC strength of the episodic memory network and AD pathology, we hypothesized that i) FC shows an age-related decrease, however, ii) FC shows an increase related to higher subsequent Aβ and tau burden, especially in APOE4 carriers. This evidence concerns the gene MAPT and Alzheimer disease.